DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Aarti Drugs Limited — Outcome of Board Meeting

NSE 6d ago·27 Aug 2026, 7:15 am

Aarti Drugs

Aarti Drugs Limited has announced the outcome of its board meeting held on August 27, 2026. While the company has not disclosed the specific agenda items discussed, such meetings are typically used to approve financial results, strategic decisions, or significant corporate actions.

For investors, this update is a routine procedural step that keeps the company's corporate governance on record. It signals that the board is actively managing the business and is ready to share any material developments with the market in due course.

Investors should wait for the official press release or detailed exchange filing to understand the exact nature of the board's decisions. Until then, the stock's performance will likely remain unaffected by this mere announcement.